McManus Donald P, Li Yuesheng, Gray Darren J, Ross Allen G
Molecular Parasitology Laboratory, Infectious Diseases Division, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, QLD 4029, Australia.
Expert Rev Anti Infect Ther. 2009 May;7(4):473-85. doi: 10.1586/eri.09.17.
Schistosomiasis japonica is a serious parasitic disease and a major health risk for more than 60 million people living in the tropical and subtropical zones of south China. The disease is a zoonosis and its cause, the parasitic trematode Schistosoma japonicum, has a range of mammalian reservoirs, making control efforts difficult. Current control programs are heavily based on community chemotherapy with a single dose of the highly effective drug praziquantel. However, vaccines (for use in bovines and in humans) in combination with other control strategies are needed to eliminate the disease. In this review, we provide an overview of the transmission, clinical features, pathogenesis, diagnosis, treatment, genetics and susceptibility, epidemiology, and prospects for control of schistosomiasis japonica in China. The threat posed by the Three Gorges Dam may undermine control efforts because it will change the local ecology and associated schistosomiasis transmission risks over the next decade and beyond.
日本血吸虫病是一种严重的寄生虫病,对生活在中国南方热带和亚热带地区的6000多万人构成重大健康风险。该疾病为人畜共患病,其病原体——寄生吸虫日本血吸虫有一系列哺乳动物宿主,这使得控制工作变得困难。当前的控制项目主要基于使用单剂量高效药物吡喹酮进行社区化疗。然而,需要(用于牛和人类的)疫苗与其他控制策略相结合以消除该疾病。在本综述中,我们概述了中国日本血吸虫病的传播、临床特征、发病机制、诊断、治疗、遗传学与易感性、流行病学以及控制前景。三峡大坝带来的威胁可能会破坏控制工作,因为在未来十年及以后它将改变当地生态以及相关的血吸虫病传播风险。